Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-08-01
2006-08-01
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S198100, C514S012200, C530S350000
Reexamination Certificate
active
07083791
ABSTRACT:
Isolated fibroblast growth factor receptor (FGFR5) polypeptides and polynucleotides encoding such polypeptides are provided. Also provided are modulators of FGFR5 gene expression and binding molecules that specifically bind to and agonize or antagonize FGFR5 polypeptide function. Specific binding molecules include antibodies, functional fragments thereof, as well as scFv and Camelidae heavy chain IgG that specifically bind to FGFR5 thereby modulating the activity of FGFR5 and, thus, are effective agents suitable for the treatment of diseases such as osteopontin-mediated autoimmune disease, such as systemic lupus erythematosus, bone disorders including osteoporosis and osteopetrosis, and cancers, including cellular carcinomas such as hepatocellular carcinomas.
REFERENCES:
patent: 2001/0016335 (2001-08-01), Young et al.
patent: 2002/0009776 (2002-01-01), Saris et al.
patent: 2002/0037557 (2002-03-01), Jing et al.
patent: 2002/0103125 (2002-08-01), Ashkenazi
patent: WO 98/49302 (1998-11-01), None
patent: WO 99/10364 (1999-05-01), None
patent: WO 99/21859 (1999-05-01), None
patent: WO 99/6308 (1999-12-01), None
patent: WO 00/24756 (2000-05-01), None
patent: WO 00/73454 (2000-12-01), None
patent: WO 01/00673 (2001-01-01), None
patent: WO 01/09327 (2001-02-01), None
patent: WO 01/49715 (2001-07-01), None
patent: WO 01/53312 (2001-07-01), None
patent: WO 01/53455 (2001-07-01), None
patent: WO 01/60991 (2001-08-01), None
patent: WO 01/70977 (2001-09-01), None
Maher, Pamela, “p38 Mitogen-activated Protein Kinase Activation is Required for Fibroblast Growth Factor-2-stimulated Cell Proliferation but not Differentiation”, The Journal of Biological Chemistry, Jun. 18, 1999, pp. 17491-17498, vol. 274, No. 25.
Bouju, Sophie, et al., “Molecular cloning and functional expression of a novel human gene encoding two 41-43 kDa skeletal muscle internal membrane proteins”, BiochemJ., 1998, pp. 594-556, vol. 335, Great Britain.
Gruss, Hans-Jürgen, and Dower, Stephen, K., “Tumor Necrosis Factor Ligand Superfamily: Involvement in the Pathology of Malignant Lymphomas”, Blood, the Journal of the American Society of Hematology, Jun. 15, 1998, pp. 3378-3404, vol. 85, No. 12.
Pietu, Genevieve, et al., “Novel Gene Transcropts Preferentially Expressed in Human Muscles Revealed by Quantitative Hybridization of a High Density cDNA Array”, Genome Research, 1996, 492-503, vol. 6.
Banner, David, W., et al. “Crystal Structure of the Soluble Human 55 kd TNF Receptor—Human TNF β Complex: Implications for TNF Receptor Activation”, Cell, May 7, 1993, pp. 431-445, vol. 73.
Yaspo, Marie-Laure, et al., “Cloning of a Novel Human Putative Type Ia Integral Membrane Protein Mapping to 21q22.3”, Genomics, Apr. 1, 1998, pp. 133-136, vol. 49.
Hattori, M., et al., GenPept Accession No. CAB90552, submitted May 5, 2000.
Pietu, G., et al., GenPept Accession No. AAC78827, submitted 1996.
Hayette, S., et al., GenPept Accession No. AAC64321, submitted 1998.
Bauer, H., et al., GenPept Accession No. AAD09175, submitted 1994.
Hemmati-Brivanlou, A., et al., GenPept Accession No. AAB30638, submitted Nov. 3, 1994.
Givol, D., GenPept Accession No. CAA41209, submitted Feb. 20, 1991.
Shi, D.L., et al., GenPept Accession No. CAA53271, submitted 1993.
Katoh, O., et al., GenPept Accession No. AAB25535, submitted 1993.
Bachner, D., et al., GenPept Accession No. CAB65272, submitted 1999.
Xu, J., et al., GenPept Accession No. AAF03400, submitted 1999.
Cabibbo, A., et al., GenPept Accession No. AAF20364, submitted 2000.
Isogai, T., et al., GenPept Accession No. BAA91786, submitted Feb. 16, 2000.
Wilson, R., et al., GenPept Accession No. AAB42225, submitted 1994.
Riboldo Tunnicliffe, G.R., et al., GenPept Accession No. AAC15584, submitted Sep. 1997.
Bouchon, A., et., GenPept Accession No. AAF69825, submitted 2000.
Shibata, T., GenPept Accession No. BAA18909, submitted Apr. 8, 1994.
Jang, w., et al., GenPept Accession No. AAC83205, submitted 1999.
Poustka, A., et al., GenPept Accession No. CAB55955, submitted Sep. 1999.
Dear, T. N., et al., Swiss-Prot Accession No. P14730, submitted 1988.
Coglievina, M., et a., Swiss-Prot Accession No. P53104, submitted 1997.
Weterman, M.A.J., et al., Swiss-Prot Accession No. Q14956, submitted 1995.
Naghpal, S., et al., Swiss-Prot Accession No. Q99969, submitted Oct. 1997.
Poustka. A., et al., PIR Accession No. T17265, submitted Oct. 15, 1999.
Shi, D.L., et al., PIR Accession No. S38579, submitted Nov. 1993.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA184346, Feb. 17, 1997.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AI119658, Sep. 2, 1998.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA231415, Feb. 26, 1997.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA498840, Jul. 1, 1997.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA636311, 1996.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AI050489, Jul. 9, 1998.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA921460, Apr. 20, 1998.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No.AI466595, Mar. 9, 1999.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AI287088, Nov. 24, 1998.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. W77540, Jun. 20, 1996.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No. AA646983, Oct. 28, 1997.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No.AI116725, Feb. 13, 1997.
Marra, M., et al., The WashU-HHMI Mouse EST Project, Accession No.AA475668, Jun. 18, 1997.
Ko, M.S.H., et al., Systematic analyses of genes expressed in fertilized mouse eggs (The ERATO/Doi Project at Wayne State University). Accession No. C86502, Mar. 11, 1998.
Sleeman, M., et al., “Identification of a new 1-15, fibroblast growth factor receptor, FGFR5” 18-20 Gene, Elsevier Biomedical Press., Amsterdam NL, Jun. 2001, vol. 271, No. 2, 27.
Murison J. Greg
Sleeman Matthew
Genesis Research & Development Corporation Limited
Li Ruixiang
Sleath Janet
Speckman Ann W.
Speckman Law Group PLLC
LandOfFree
Methods for enhancing immune responses by fibroblast growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancing immune responses by fibroblast growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing immune responses by fibroblast growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632720